Yahoo
Tokyo - Delayed Quote JPY

Alfresa Holdings Corporation (2784.T)

2,441.50 -27.50 (-1.11%)
At close: 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
Name Title Pay Exercised Year Born
Mr. Ryuji Arakawa
President & Representative Director -- -- 1963
Mr. Yusuke Fukujin
Executive VP & Representative Director -- -- 1976
Mr. Shigeki Ohashi
Director & Senior Managing Executive Officer -- -- 1965
Mr. Toshiki Tanaka
Director & Senior Managing Executive Officer -- -- 1963
Mr. Kazuaki Hano
Executive Officer -- -- --
Mr. Soichi Nemoto
Executive Officer -- -- --
Toshikazu Urakabe
Executive Officer -- -- --
Mr. Takashi Sasaki
Executive Officer -- -- --
Miki Oguchi
Senior Executive Officer -- -- --
Naruhiko Sano
Executive Officer -- -- --

Alfresa Holdings Corporation

Ote Center Building
23rd floor 1-1-3 Otemachi
Chiyoda, 100-0004
Japan
81 3 5219 5100 https://www.alfresa.com
Sector: 
Healthcare
Industry: 
Medical Distribution
Full Time Employees: 
12,525

Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products; and engages in insurance agency, real estate management, and sales of daily necessities and consumables activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Chiyoda, Japan.

Corporate Governance

Alfresa Holdings Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 9, 2026 at 6:30 AM UTC

Alfresa Holdings Corporation Earnings Date

March 30, 2027 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: